Search PubMed⌕ Search

Biomedical subjects

M Bartels

Publications and source records attributed to M Bartels.

At least 91 records · Page 5Linked to original sources

[Cerebellar side effects in treatment with antidepressive agents].

Nine patients are reported with marked cerebellar side-effects under antidepressant treatment, mostly in combination with other psychopharmacological agents. The main symptoms were dysmetria, ataxia, intentional tremor, dysarthria and rarely myocloni. In nearly all cases symptomatology disappeared by slight dosis reduction of the antidepressant. Pathophysiology could be best explained by influence on nonadrenergic afferences of cerebellar cortex.

Adult↗

[Experimental study of forehead temperature in autogenic training].

Thermometry of the forehead and cheeks was done in 35 longtime trainees of Autogenic Training (AT). Results revealed a significant increase in forehead skin temperature rather than the hypothesized decrease. Cheek temperature rose significantly more than forehead temperature. This difference between cheek and forehead temperatures could explain the subjective impression of coolness of the forehead during the sixth standard exercise of Autogenic Training.

Adult↗

Treatment of akathisia with lorazepam. An open clinical trial.

Sixteen patients with neuroleptic-induced akathisia were treated with lorazepam. A marked improvement in symptoms was observed in 9 of the patient and moderate improvement in 5. Symptoms remained unchanged in 2 patients. The drop in the akathisia score from a pretreatment value of 1.81 to 0.5 after 7 days and to 0.32 after 14 days was statistically significant. Symptoms did not improve significantly during observation of the spontaneous course. No severe side effects were observed. The physiologic mechanisms of action of lorazepam on the akathisia syndrome are discussed.

Adult↗

Differential effects of a new dibenzo-epine neuroleptic compared with haloperidol. Results of an open and crossover study.

Fluperlapine (NB-106-689) was tested on 26 schizophrenic patients in an open and crossover study. In addition to its good antipsychotic effect, it also alleviated the apathic and depressive syndromes. Six patients who had shown only slight or no improvement after 4 weeks of haloperidol therapy responded positively to fluperlapine. The alleviation of the anergic syndrome was especially impressive. The therapeutic response of the depressive-apathic syndromes could represent an important extension of pharmacotherapy for schizophrenia. The virtual lack of extrapyramidal motor side effects with fluperlapine supports an intensification of the search for other nonclassic dibenzo-epine neuroleptics.

Adolescent↗

Increased functional vulnerability to acute compression injury of a spinal cord segment under barbiturate anesthesia.

Posttraumatic changes in polysynaptic reflex activity and axonal long-tract conduction were measured after transient compression of the L-7 spinal cord segment of cats, either made high spinal and unanesthetized or left intact under pentobarbital anesthesia. The severity of acute post-injury changes increased significantly in the anesthetized animals. Partial recovery and stabilization of functional deficits were observed in the spinal cat, but not in the anesthetized one. These findings suggest that, at least in the acute postinjury stage, pentobarbital anesthesia may enhance functional damages after experimental spinal cord compression.

Animals↗

Acute effects of dexamethasone on normal and on posttraumatic spinal cord polysynaptic reflex activity and axonal conduction.

The effects of a single intravenous injection of a high dose of dexamethasone (4 mg/kg) on polysynaptic reflex activity and axonal conduction were measured for 5 hours in the intact and in the compression-injured L-7 spinal cord segment of high spinal cats. The segment was injured by a transient compression of preset degree and duration. In the uninjured preparation, dexamethasone administration significantly reduced polysynaptic reflex size for 2 hours. Axonal conduction was unaltered. One group of injured animals was given dexamethasone 30 minutes after trauma, whereas another was not treated. The acute posttraumatic changes in both parameters did not differ significantly in treated and untreated animals. Histopathologically, differences in the amount of segmental edema and hemorrhage between untreated and treated animals were not significant.

Animals↗

Acute changes in somatosensory evoked potentials following graded experimental spinal cord compression.

Amplitude and latency of cortical somatosensory potentials evoked in cats by peripheral nerve stimulation were measured before, during, and for 5 hours after injury of spinal cord segment L-7 by a predetermined degree and duration of compression. An amplitude decrease, slight and transitory, was first observed after compression reduced the segmental cross section by 60%. After an 80% compression, amplitude reduction was initially larger and lasted longer, but recovered 2.5 hours after injury to a level that did not differ statistically from control values. After total (100%) compression, evoked responses disappeared abruptly and did not recover significantly. Latency was unaltered at all degrees of compression. Structural damage increased with the degree of compression. In this model, evoked potential changes neither reflect nor predict the magnitude of acute incomplete spinal cord injury.

Animals↗

Fluorinated psychopharmacological agents: noninvasive observation by fluorine-19 nuclear magnetic resonance.

Fluorinated psychopharmacological agents were measured with fluorine-19 nuclear magnetic resonance spectroscopy in the brain of intact rats that had been treated with fluphenazine. These in vivo experiments were compared to in vitro measurements of fluphenazine-treated rats. A high-field shift was observed in both in vivo and in vitro measurements. On the basis of the in vitro measurements, fluphenazine concentration in the brains of treated rats was estimated. Our observations demonstrate the feasibility of this technique for determining fluorinated neuroleptics in live mammals.

Animals↗

[Magnetic resonance tomography and safety. Electroencephalographic and neuropsychologic findings before and after MR studies of the brain].

The influence of MR on the EEG and neuropsychological functions was investigated. An EEG was done in 8 of 20 patients before and after 0.5 Tesla MRI. Computerized EEG analysis showed no significant differences in respect of the dominant frequency and the power spectrum. The memory functions of 12 patients were investigated by clinically proven neuropsychological tests before and after MRI (0.5 and 1.5 tesla). The results demonstrated no measurable influence of MRI on cognitive functions.

Brain Injuries↗

Reflex activity and axonal conduction in the L-7 spinal cord segment following experimental compression trauma.

In cats in which the spinal cord was transected at C-1, the exposed L-7 spinal cord segment was compressed with an electromagnetically driven rod applied to the dorsal surface of the segment. With the magnitude of compression constant at 3 mm, the cord was compressed for durations of 50 msec, 0.5 sec, or 1.0 sec. Polysynaptic reflex discharges integrated in the injured segment and action potentials conducted in dorsal column axons traversing the same region were electrophysiologically measured before, during, and for 41/2 hours after trauma. Structural changes were evaluated on frozen serial sections obtained both from compressed segments and from tissue adjacent to the injury. At a compression duration of 50 msec, the amplitude of evoked reflex activity decreased abruptly, and dorsal column axonal conduction was blocked for 1 minute following compression. This early-phase response was followed by partial recovery of both functions which persisted until the end of the experiment. Prolonging compression to 0.5 sec brought about a further decrease of polysynaptic reflex activity. Axonal conduction was also decreased, but not significantly. With compression lasting 1.0 sec, no significant changes in reflex discharges and axonal conduction occurred compared with those measured at 0.5 sec. Neither function was abolished, even after the longest compression time. Prolongation of compression significantly increased both the intensity and the spread of edema, whereas changes in hemorrhage were not significant. Thus, a plateau rather than a progressive increase in severity of functional and structural posttraumatic changes was reached by increasing the duration of compression. This injury model reduces the sources of variability found in other experimental compression trauma models and permits the quantitative assessment of basic spinal cord mechanisms and correlated histopathological changes in the same preparation following trauma.

Animals↗

[Cerebral seizures in neuroleptic therapy].

Basing on a review of the literature and on own research, the authors examine the incidence rate of convulsions under neuroleptic treatment. In addition, the authors go into the neurophysiological and neuropharmacological mechanisms of the convulsive action of neuroleptics. An attempt is made to present information on the incidence rate of attacks and on the clinical conditions on the basis of individual case reports and drug studies. Calculation of incidence ratio beyond a rough estimate is rendered difficult by heterogeneity of random samples and incomplete data. The incidence rate was found to be approx. 1 per cent in a random sample of schizophrenics and schizo-affective patients (n = 730) at the Department of Psychiatry of the University of Tübingen.

Antipsychotic Agents↗

Tetrabenazine (Nitoman) therapy of chronic spontaneous oral dyskinesia. A video- and EMG-controlled study.

Therapeutic results achieved with tetrabenazine in six patients with spontaneous oral dyskinesia were evaluated by clinical rating as well as time-blind video and EMG assessment. Dramatic improvement of symptoms was observed in five of our six patients and good to satisfactory improvement in the remaining patient. The correspondence among clinical findings, EMG data, and video analysis was good. Medication was started at low doses and slowly increased. Adverse reactions (i.e., rigidity, akinesia, vasodepression) were minimal.

Aged↗

Amisulpride--an open clinical study of a new benzamide in schizophrenic patients.

In pharmacological screening amisulpride produces no catalepsy, no inhibition of stereotypic movements, yet a blockade of drug-induced vomiting. During an open clinical trial lasting 4 weeks, 14 patients (13 schizophrenics) were treated with the compound. The (BPRS-) syndromes anxiety/depression, thought disorder, activity, hostility and the global score showed significant improvement. With the AMDP system significant changes were seen in the paranoid-hallucinatory, manic, depressive and hostility syndromes as well as in the global score. No changes were revealed in anergia (BPRS) and apathia (AMDP). In the EEG a significant decrease in the frequency of alpha-rhythms was found. The scores of the Simpson-scale for extrapyramidal side effects were low, but there was an acute dystonic reaction in one patient. In three cases akathisia occurred; biperiden administration was necessary three times. In conclusion, amisulpride showed good antipsychotic efficacy without sedation. Contrary to expectations based on the pharmacological screening, we did find extrapyramidal side effects.

Adult↗

Antipsychotic efficacy of fluperlapine. An open multicenter trial.

In an open multicenter trial 46 schizophrenic patients were treated with fluperlapine for 20 days. A mean daily dosage of 300-400 mg appeared to be an effective antipsychotic treatment in most cases. The marked antipsychotic effect was accompanied by a good improvement of depressive symptoms. Extrapyramidal side effects were extremely rare.

Adult↗